Clinical Trials
6 trialsNCT05459441 2022-07-15
Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases
Shanghai Pudong Hospital
Phase EARLY_PHASE1 Unknown
NCT05333588 2022-04-19
The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
Hebei Senlang Biotechnology Inc., Ltd.
Phase EARLY_PHASE1 Unknown
NCT03347097 2021-08-25
Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
Huashan Hospital
Phase EARLY_PHASE1 Unknown
NCT04045847 2020-05-07
CD147-CART Cells in Patients With Recurrent Malignant Glioma.
Xijing Hospital
Phase EARLY_PHASE1 Unknown
NCT01801371 2017-04-07
GRGDG
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT02520882 2017-04-07
68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown